L

Lowell General Hospital | Cancer Center

Research site
(Unclaimed)
Location
295 Varnum Avenue, Lowell, Massachusetts, United States of America
Site insights

Top conditions

Breast Cancer (41 trials)

Carcinoma (31 trials)

Lung Cancer (19 trials)

Prostatic Cancer (11 trials)

Non-Small-Cell Lung Carcinoma (8 trials)

Top treatments

Paclitaxel
Carboplatin
Bevacizumab
Exemestane
Palbociclib
Cisplatin
Crizotinib
Erlotinib Hydrochloride
Atezolizumab
Cyclophosphamide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 112
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

This is a single arm, phase II trial of combined neoadjuvant platinum doublet chemotherapy plus durvalumab followed by surgery, postoperative radiati...

Active, not recruiting
Stage IIIB Non-small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Radiation: Radiotherapy
Drug: Durvalumab

Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemo...

Active, not recruiting
Ovarian Neoplasms
Fallopian Tube Adenocarcinoma
Drug: Paclitaxel
Drug: Carboplatin

This is a prospective, two arm, international, multicenter, randomized, open-label Phase III study evaluating the addition of 2 years of palbociclib...

Active, not recruiting
Breast Cancer
Drug: Standard Adjuvant Endocrine Therapy
Drug: Palbociclib

The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior t...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in pa...

Enrolling
Prognostic Stage IA Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Other: Questionnaire Administration
Other: Quality-of-Life Assessment

Trial sponsors

National Cancer Institute (NCI) logo

National Cancer Institute (NCI) (30 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems